Literature DB >> 12784310

Alport syndrome with diffuse leiomyomatosis.

Martina C Anker1, Joachim Arnemann, Katrin Neumann, Peter Ahrens, Helga Schmidt, Rainer König.   

Abstract

Alport syndrome (AS) is a hereditary nephropathy with hematuria progressing to end-stage renal failure (ESRF), sensorineural deafness, and specific eye signs (lenticonus, macular flecks, and congenital cataracts). Inheritance is X-linked in about 85% of the cases, caused by different mutations in the COL4A5 gene. Rarely AS is seen in combination with diffuse leiomyomatosis (DL). DL is a tumorous process involving smooth muscle cells, mostly of the esophagus, but also of the tracheobronchial tree and the female genital tract. Characteristically, the patients have deletions of the 5'-end of both the COL4A5 and the COL4A6 genes, respectively. We here present a 9-year-old boy who was admitted because of a newly diagnosed sensorineural deafness. He was born with cataracts and presented symptoms of dysphagia and bronchial irritation in the first year of life. Macroscopic hematuria was first noticed at 2 years during a febrile infection. Since early childhood the boy suffered from severe constipation. Taking together these symptoms, the diagnosis of Alport syndrome with diffuse leiomyomatosis (AS-DL) has to be considered. Genetic analysis demonstrated the predicted deletion of the COL4A5/COL4A6 genes. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12784310     DOI: 10.1002/ajmg.a.20019

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

Review 1.  Exploring the genetic basis of early-onset chronic kidney disease.

Authors:  Asaf Vivante; Friedhelm Hildebrandt
Journal:  Nat Rev Nephrol       Date:  2016-01-11       Impact factor: 28.314

2.  [Leiomyomatosis of the colon: case report and literature review].

Authors:  B-C Padberg; A Emmermann; C Zornig; M Germer; S Schröder
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

Review 3.  Modulation of polycystic kidney disease by non-coding RNAs.

Authors:  Harini Ramalingam; Matanel Yheskel; Vishal Patel
Journal:  Cell Signal       Date:  2020-01-23       Impact factor: 4.315

4.  Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus: an extension of the Col4a1 allelic series and the identification of the first two Col4a2 mutant alleles.

Authors:  Jack Favor; Christian Johannes Gloeckner; Dirk Janik; Martina Klempt; Angelika Neuhäuser-Klaus; Walter Pretsch; Wolfgang Schmahl; Leticia Quintanilla-Fend
Journal:  Genetics       Date:  2006-12-18       Impact factor: 4.562

Review 5.  Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.

Authors:  Arno E Commandeur; Aaron K Styer; Jose M Teixeira
Journal:  Hum Reprod Update       Date:  2015-07-03       Impact factor: 15.610

6.  Diffuse uterine leiomyomatosis in a child.

Authors:  Deepa Pai; Monette C Coletti; Matthew Elkins; Maria Ladino-Torres; Elaine Caoili
Journal:  Pediatr Radiol       Date:  2011-06-28

7.  Leiomyomatosis of the esophagus: experience over a decade.

Authors:  Vikas Gupta; Anupam Lal; Saroj K Sinha; Ritambhra Nada; Narendar M Gupta
Journal:  J Gastrointest Surg       Date:  2008-09-26       Impact factor: 3.452

8.  Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease.

Authors:  Naoki Nakagawa; Luke Barron; Ivan G Gomez; Bryce G Johnson; Allie M Roach; Sei Kameoka; Richard M Jack; Mark L Lupher; Sina A Gharib; Jeremy S Duffield
Journal:  JCI Insight       Date:  2016-12-08

9.  Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6.

Authors:  Simone Rost; Elisa Bach; Cordula Neuner; Indrajit Nanda; Sandra Dysek; Reginald E Bittner; Alexander Keller; Oliver Bartsch; Robert Mlynski; Thomas Haaf; Clemens R Müller; Erdmute Kunstmann
Journal:  Eur J Hum Genet       Date:  2013-05-29       Impact factor: 4.246

Review 10.  [Motility disorders of the esophagus].

Authors:  E Bruder; A-L Rougemont; R I Furlano; J F Schneider; J Mayr; F-M Haecker; K Beier; J Schneider; P Weber; T Berberich; G Cathomas; W A Meier-Ruge
Journal:  Pathologe       Date:  2013-03       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.